as 05-20-2024 9:34am EST
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range.
Upcoming Earnings Alert:
Get ready for potential market movements as Alpha Tau Medical Ltd. DRTS prepares to release earnings report on 24 May 2024.
Founded: | 2015 | Country: | Israel |
Employees: | N/A | City: | N/A |
Market Cap: | 183.5M | IPO Year: | N/A |
Target Price: | $11.75 | AVG Volume (30 days): | 35.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.42 | EPS Growth: | N/A |
52 Week Low/High: | $2.15 - $4.80 | Next Earning Date: | 05-24-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
DRTS Breaking Stock News: Dive into DRTS Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
GlobeNewswire
14 days ago
GlobeNewswire
19 days ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
Simply Wall St.
3 months ago
GlobeNewswire
4 months ago